Archive for the 'Raptiva' Category

Defective drug Raptiva threatens psoriasis patients


As many as seven million Americans suffer psoriasis, a condition causing inflammation and red scaly patches on the skin, as well as psoriatic plaques on the knees and elbows. An autoimmune disease, Psoriasis can be treated, but it can’t be cured.

Unfortunately, one such treatment may be worse than psoriasis itself. That treatment is the medication called Raptiva, an injectable drug produced by California-based biotechnology giant Genentech. The Food and Drug Administration has just issued an advisory on Raptiva after learning that three psoriasis patients using Raptiva died from neurological infections.

(more…)